Verve Therapeutics Stock Forward View - Accumulation Distribution

VERVDelisted Stock  USD 11.13  0.00  0.00%   
Verve Stock outlook is based on your current time horizon.
The value of RSI of Verve Therapeutics' share price is above 70 at this time. This entails that the stock is becoming overbought or overvalued. The idea behind Relative Strength Index (RSI) is that it helps to track how fast people are buying or selling Verve, making its price go up or down.

Momentum 71

 Buy Stretched

 
Oversold
 
Overbought
The successful prediction of Verve Therapeutics' future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Verve Therapeutics and does not consider all of the tangible or intangible factors available from Verve Therapeutics' fundamental data. We analyze noise-free headlines and recent hype associated with Verve Therapeutics, which may create opportunities for some arbitrage if properly timed.
Using Verve Therapeutics hype-based prediction, you can estimate the value of Verve Therapeutics from the perspective of Verve Therapeutics response to recently generated media hype and the effects of current headlines on its competitors.

Verve Therapeutics after-hype prediction price

    
  USD 11.13  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as delisted stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
  
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in poverty.

Verve Therapeutics Additional Predictive Modules

Most predictive techniques to examine Verve price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Verve using various technical indicators. When you analyze Verve charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
Verve Therapeutics has current Accumulation Distribution of 0. The accumulation distribution (A/D) indicator shows the degree to which Verve Therapeutics is accumulated by the market over a given period. It uses the quote sensitivity to the highest or lowest daily price of Verve Therapeutics to determine if accumulation or reduction is taking place in the market. This value is adjusted by Verve Therapeutics trading volume to give more weight to distributions with higher volume over lower volume.
Check Verve Therapeutics VolatilityBacktest Verve TherapeuticsInformation Ratio  

Verve Therapeutics Trading Date Momentum

On February 03 2026 Verve Therapeutics was traded for  11.13  at the closing time. The top price for the day was 11.13  and the lowest listed price was  11.13 . There was no trading activity during the period 0.0. Lack of trading volume on February 3, 2026 did not result in any price rise and fall. The trading price change against the current closing price is 0.00% .
Accumulation distribution indicator can signal that a trend is either nearing completion, at a continuation, or is about to break-outs. The actual value of this indicator is of no significance. What is significant is the change in value of over time. The formula for A/D of a given trading day can be expressed as follow: ((Close - Low) - (High - Close)) / (High - Low) X Volume
Compare Verve Therapeutics to competition

Verve Therapeutics Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Verve Therapeutics stock to make a market-neutral strategy. Peer analysis of Verve Therapeutics could also be used in its relative valuation, which is a method of valuing Verve Therapeutics by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

Verve Therapeutics Market Strength Events

Market strength indicators help investors to evaluate how Verve Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Verve Therapeutics shares will generate the highest return on investment. By undertsting and applying Verve Therapeutics stock market strength indicators, traders can identify Verve Therapeutics entry and exit signals to maximize returns.

Verve Therapeutics Risk Indicators

The analysis of Verve Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Verve Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting verve stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Story Coverage note for Verve Therapeutics

The number of cover stories for Verve Therapeutics depends on current market conditions and Verve Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Verve Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Verve Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Verve Therapeutics Short Properties

Verve Therapeutics' future price predictability will typically decrease when Verve Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Verve Therapeutics often depends not only on the future outlook of the potential Verve Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Verve Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding84.7 M
Cash And Short Term Investments524.3 M
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in poverty.
You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Other Consideration for investing in Verve Stock

If you are still planning to invest in Verve Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Verve Therapeutics' history and understand the potential risks before investing.
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites